Are Phio Pharmaceuticals Corp (NASDAQ: PHIO) Shares Ready For A Price Rise?

In the last trading session, 280.14 million Phio Pharmaceuticals Corp (NASDAQ:PHIO) shares changed hands as the company’s beta touched 1.51. With the company’s per share price at $6.60 changed hands at $4.91 or 290.53% during last session, the market valuation stood at $11.44M. PHIO’s last price was a discount, traded about -56.82% off its 52-week high of $10.35. The share price had its 52-week low at $1.53, which suggests the last value was 76.82% up since then. When we look at Phio Pharmaceuticals Corp’s average trading volume, we note the 10-day average is 0.17 million shares, with the 3-month average coming to 367.04K.

Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information

Instantly PHIO was in green as seen at the end of in last trading. With action 235.03%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 266.67%, with the 5-day performance at 235.03% in the green. However, in the 30-day time frame, Phio Pharmaceuticals Corp (NASDAQ:PHIO) is 134.88% up. Looking at the short shares, we see there were 51491.0 shares sold at short interest cover period of 0.5 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 62.38%.

PHIO Dividends

Phio Pharmaceuticals Corp is expected to release its next quarterly earnings report in February.

Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 4.81% of Phio Pharmaceuticals Corp shares while 3.02% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.17%.